Author(s): Tse TW, Hui E, Tse TW, Hui E, Tse TW, Hui E
Abstract Share this page
Abstract This article reviews an old drug tranexamic acid to its new use in the treatment of melasma. Its mechanism of preventing the activation of melanocyte from UV light, hormone and injured kerationcyte through the inhibition of the plasminogen activator system will be explored. The detail usage for such indication and its safety profile will also be thoroughly evaluated. © 2013 Wiley Periodicals, Inc.
This article was published in J Cosmet Dermatol
and referenced in Journal of Clinical & Experimental Dermatology Research